RNA Horizons 2025 Showcases Advances in RNA Therapeutics in Palermo

November 11, 2025
The RNA Horizons Therapeutics Symposium 2025 gathered researchers and biotech leaders in Palermo to discuss advances in RNA delivery, stability, and clinical translation, with the next event scheduled for Munich in 2026.

The RNA Horizons Therapeutics Symposium 2025 brought together scientists, clinicians, and biotech innovators in Palermo, Italy, to present new findings in RNA biology and medicine, announced in a press release. The three-day event followed the 2024 edition in Porto and focused on RNA’s growing role in treating oncology, metabolic, and neurodegenerative diseases.

Key discussions centered on improving RNA delivery and stability, including antisense oligonucleotides and self-amplifying RNA. Highlights featured Prof. Ernesto Guccione’s NATURA assay for high-throughput RNA delivery measurement, Prof. Shai Rosenberg’s transcriptomic modeling for precision therapies, and Prof. Ron Weiss’s miRNA-based logic circuits for selective cancer targeting.

Other presentations included 3D-bioprinted tumoroid models by Prof. Ronit Satchi-Fainaro, studies on splicing dysregulation by Prof. Claudio Sette, and m⁶A-dependent RNA regulation findings from Prof. Rotem Karni. Additional talks expanded the focus to metabolic and neurodevelopmental disorders.

The symposium, organized by RNA Horizons under the CANCERNA consortium, emphasized collaboration across academia, industry, and clinical research. The next RNA Horizons Therapeutics Symposium will be held in Munich, Germany, in September 2026.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

11/11
EXoPERT Joins Johnson & Johnson’s JLABS TMC to Advance AI Cancer Diagnostics
11/11
Expanse Medical Opens Providence Facility with Support from Rhode Island Life Science Hub
11/11
Scientist.com CTO Chris Petersen Named 2025 CTO of the Year by 7CTOs
11/10
National Health Council Launches PXI to Involve Patients in Health AI Innovation
11/10
Akkodis Demonstrates AI-Led Innovations Across Industries

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like